Koyfin Home > Directory > Health Care > Biogen Inc > Total Debt / Equity

Biogen Inc Total Debt / Equity Chart (BIIB)

Biogen Inc annual/quarterly Total Debt / Equity from 2010 to 2020. Debt to equity is a measure of leverage in a company and expressed as a ratio of the total debt relative to book value of equity.
  • Biogen Inc Total Debt / Equity for the quarter ending September 09, 2020 was $73m a 33.77% increase of 25m year over year
  • Biogen Inc Total Debt / Equity for the last 12 months ending September 09, 2020 was $73m a 33.77% increase of 25m year over year
  • Biogen Inc Annual Total Debt / Equity for 2019 was $48m a 5.66% increase of 3m from 2018
  • Biogen Inc Annual Total Debt / Equity for 2018 was $46m a -3.47% decrease of -2m from 2017
  • Biogen Inc Annual Total Debt / Equity for 2017 was $47m a -14.00% decrease of -7m from 2016
Other Ratios Metrics:
  • Biogen Inc Total Debt / Capital for the quarter ending December 12, 2018 was $31m a 5.08% increase of 2m year over year
  • Biogen Inc Other Liabilities for the quarter ending December 12, 2018 was $3,026m a 1.80% increase of 55m year over year
View Chart On Koyfin

Quarterly BIIB Total Debt / Equity Data

09/2020$73m
06/2020$69m
03/2020$51m
12/2019$48m
09/2019$46m
06/2019$50m
03/2019$47m
12/2018$46m
09/2018$43m
06/2018$48m

Annual BIIB Total Debt / Equity Data

2019$48m
2018$46m
2017$47m
2016$54m
2015$70m
2014$5m
2013$7m
2012$16m
2011$17m
2010$22m